COVID-19
1
COVID-19 retningslinje (2024v30)
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem.
Ændringer siden version 29:
Indikationer for COVID-19 test er tilføjet.
2
Antivirale midler til SARS-CoV-2 (2022)
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
1
Aktuelle tal (SSI)
https://experience.arcgis.com/experience/220fef27d07d438889d651cc2e00076c/page/Covid-19-Regionalt
1
SSI's epidemiologiske rapporter med særligt fokus på udvalgte perspektiver af COVID-19 udbruddet
2
Sundhedsstyrelsens side om COVID-19
3
Sundhedsstyrelsens Nationale Kliniske Anbefaling: Brug af lægemidler ved forebyggelse og behandling af COVID-19
1
Effectiveness and acceptability of the unified protocol for the transdiagnostic treatment of emotional disorders in people with long COVID-19: Study protocol for a randomized controlled trial
PLoS One Infectious Diseases
Tilføjet 18. februar 2026
2
Trends and predictors of caesarean section in Thailand before and during the COVID-19 pandemic: a retrospective analysis of national hospitalisation data under the Universal Coverage Scheme
BMJ Open
Tilføjet 17. februar 2026
3
Redefining ‘normal’: A Canadian case study of cancer survivors’ experiences remaining and/or returning to work during the COVID-19 pandemic
PLoS One Infectious Diseases
Tilføjet 14. februar 2026
4
Food insecurity and COVID-19-related experiences among people with HIV: A mixed methods analysis and conceptual framework
PLoS One Infectious Diseases
Tilføjet 13. februar 2026
5
Learning from patients about their experiences with early adoption of virtual care appointments in primary care in Ontario, Canada during the COVID-19 pandemic: a qualitative study
BMJ Open
Tilføjet 13. februar 2026
6
Rare, dangerous side effects from COVID-19 vaccines explained
Science
Tilføjet 13. februar 2026
7
Correction: Investigating the causal effects of COVID-19 vaccination on the adoption of protective behaviors in Japan: Insights from a fuzzy regression discontinuity design
PLoS One Infectious Diseases
Tilføjet 10. februar 2026
8
Spatial patterns and environmental influences of COVID-19 outbreaks, post-Omicron
PLoS One Infectious Diseases
Tilføjet 10. februar 2026
9
Psychological burden and its association with preferred form of psychological assistance of healthcare workers during the COVID-19 pandemic in China: a cross-sectional study
BMJ Open
Tilføjet 10. februar 2026
10
Spatiotemporal dynamics and multiple driving factors of antimicrobial resistance in China during the COVID-19 pandemic (2019–2023): a provincial panel data analysis
Antimicrobial Agents And Chemotherapy
Tilføjet 10. februar 2026
11
[World Report] Millions of Americans lose health insurance as COVID-19 era subsidies end
Lancet
Tilføjet 6. februar 2026
12
Assessing knowledge levels on coronavirus disease (COVID-19) among community members: The influence of community engagement efforts in Seke district, Zimbabwe: A cross-sectional study
PLoS One Infectious Diseases
Tilføjet 7. februar 2026
13
Recurrent COVID-19 infection and the risk of exacerbation, mortality and long covid in patients with chronic obstructive pulmonary disease: a nationwide retrospective cohort study
BMJ Open
Tilføjet 6. februar 2026
14
Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemic
BMJ Open
Tilføjet 5. februar 2026
15
Comparative Evaluation of SARS-CoV-2 Antigens as Capture and Detection Elements in an In-House Antigen-Based ELISA for COVID-19 Total Antibody Detection
International Journal of Infectious Diseases
Tilføjet 4. februar 2026
16
Regional political climate’s moderating role in the association between political conservatism and COVID-19 vaccine hesitancy in the United States
PLoS One Infectious Diseases
Tilføjet 4. februar 2026
17
The cost and cost drivers of delivering COVID-19 vaccines in low- and middle-income countries: a bottom-up costing study of rollouts in seven countries
PLoS One Infectious Diseases
Tilføjet 3. februar 2026
18
Associations of C-reactive protein-albumin-lymphocyte (CALLY) index with severity and prognosis in COVID-19 patients
International Journal of Infectious Diseases
Tilføjet 3. februar 2026
19
Clinical outcomes of immunocompromised patients administered tixagevimab–cilgavimab as pre-exposure prophylaxis for COVID-19: real-world experience in Taiwan
International Journal of Infectious Diseases
Tilføjet 3. februar 2026
20
Facility-specific epidemiological characteristics of COVID-19 clusters across SARS-CoV-2 variant waves in South Korea
International Journal of Infectious Diseases
Tilføjet 2. februar 2026